Article

Luxottica Group adapts to economic environment

Luxottica Group is carrying out a number of cost-cutting measures, including store closings, manufacturing reductions, and cuts in advertising. These changes came after the company's net income in 2008 fell to €395 million, down 17.6%.

Key Points

Milan-Luxottica Group is carrying out a number of cost-cutting measures, including store closings, manufacturing reductions, and cuts in advertising. These changes came after the company's net income in 2008 fell to 395 million, down 17.6%.

One hundred seventeen stores in North America will close, 56 additional Pearle Vision locations will be franchised by the end of the year, and 110 retail units are under review, according to Andrea Guerra, chief executive officer, Luxottica. Overall, a 2% to 3% reduction in its global store count is planned, according to the company.

Its eyewear manufacturing volume will be reduced by 15%, three low-performing brands will be eliminated, and its number of frame styles will be reduced.

"We have already implemented a series of measures that will enable us to adapt rapidly and flexibly to the new environment, and that will both contribute to boosting sales and streamline our cost structure across all divisions and geographic regions," Guerra said. He added that Luxottica is "rapidly adapting our manufacturing, distribution and sales capacity to the new needs of the market."

The company also is revising the merchandise mix of its Sunglass Hut stores in North America, within Luxottica Retail, by putting more emphasis on the popular retail selling points between $50 and $150.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.